{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:50:49Z","timestamp":1785509449680,"version":"3.56.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2022YFC2406900"],"award-info":[{"award-number":["2022YFC2406900"]}]},{"name":"National Key Research and Development Program of China","award":["2022YFC2406904"],"award-info":[{"award-number":["2022YFC2406904"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82394434"],"award-info":[{"award-number":["82394434"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00259-025-07533-3","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T10:41:27Z","timestamp":1756896087000},"page":"1211-1221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cranial glucose metabolic patterns across prodromal and clinical parkinson\u2019s disease revealed by 18F-FDG PET"],"prefix":"10.1007","volume":"53","author":[{"given":"Weizhao","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianbin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoling","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixiao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0425-3921","authenticated-orcid":false,"given":"Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"issue":"10291","key":"7533_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397(10291):2284\u2013303.","journal-title":"Lancet"},{"issue":"11","key":"7533_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"GBD 2016 Parkinson\u2019s Disease Collaborators","year":"2018","unstructured":"GBD 2016 Parkinson\u2019s Disease Collaborators. Global, regional, and national burden of parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2018;17(11):939\u201353.","journal-title":"Lancet Neurol"},{"issue":"3","key":"7533_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3233\/JPD-230328","volume":"14","author":"S Maheshwari","year":"2024","unstructured":"Maheshwari S, Akram H, Bulstrode H, et al. Dopaminergic cell replacement for parkinson\u2019s disease: addressing the intracranial delivery hurdle. J Parkinsons Dis. 2024;14(3):415\u201335.","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"7533_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13578-021-00702-5","volume":"11","author":"L Xiong","year":"2021","unstructured":"Xiong L, Pan JX, Guo HH, Mei L, Xiong WC. Parkinson\u2019s in the bone. Cell Biosci. 2021;11(1):190.","journal-title":"Cell Biosci"},{"issue":"6","key":"7533_CR5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jbspin.2015.03.009","volume":"82","author":"S Malochet-Guinamand","year":"2015","unstructured":"Malochet-Guinamand S, Durif F, Thomas T. Parkinson\u2019s disease: a risk factor for osteoporosis. Joint Bone Spine. 2015;82(6):406\u201310.","journal-title":"Joint Bone Spine"},{"issue":"3","key":"7533_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/17446651.2020.1756772","volume":"15","author":"CA Figueroa","year":"2020","unstructured":"Figueroa CA, Rosen CJ. Parkinson\u2019s disease and osteoporosis: basic and clinical implications. Expert Rev Endocrinol Metab. 2020;15(3):185\u201393.","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"2","key":"7533_CR7","doi-asserted-by":"publisher","first-page":"e763","DOI":"10.1210\/clinem\/dgaa864","volume":"106","author":"SH Feng","year":"2021","unstructured":"Feng SH, Huang YP, Yeh KC, Pan SL. Osteoporosis and the risk of parkinson\u2019s disease: a nationwide, propensity Score-Matched, longitudinal Follow-up study. J Clin Endocrinol Metab. 2021;106(2):e763\u201371.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"7533_CR8","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1002\/mds.29567","volume":"38","author":"P Gonzalez-Latapi","year":"2023","unstructured":"Gonzalez-Latapi P, Lo RY. Bone first or brain first: picking at the bones of parkinson\u2019s disease. Mov Disord. 2023;38(9):1579\u201381.","journal-title":"Mov Disord"},{"key":"7533_CR9","first-page":"e920846","volume":"26","author":"Y Wang","year":"2020","unstructured":"Wang Y, Wang Z. An integrated network analysis of mRNA and gene expression profiles in parkinson\u2019s disease. Med Sci Monit. 2020;26:e920846.","journal-title":"Med Sci Monit"},{"issue":"1","key":"7533_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1359\/JBMR.050904","volume":"21","author":"JB van Meurs","year":"2006","unstructured":"van Meurs JB, Rivadeneira F, Jhamai M, et al. Common genetic variation of the low-density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men. J Bone Min Res. 2006;21(1):141\u201350.","journal-title":"J Bone Min Res"},{"issue":"22","key":"7533_CR11","doi-asserted-by":"publisher","first-page":"4966","DOI":"10.1093\/hmg\/dds342","volume":"21","author":"DC Berwick","year":"2012","unstructured":"Berwick DC, Harvey K. LRRK2 functions as a Wnt signaling scaffold, bridging cytosolic proteins and membrane-localized LRP6. Hum Mol Genet. 2012;21(22):4966\u201379.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"7533_CR12","first-page":"209","volume":"14","author":"V Domazetovic","year":"2017","unstructured":"Domazetovic V, Marcucci G, Iantomasi T, Brandi ML, Vincenzini MT. Oxidative stress in bone remodeling: role of antioxidants. Clin Cases Min Bone Metab. 2017;14(2):209\u201316.","journal-title":"Clin Cases Min Bone Metab"},{"issue":"6","key":"7533_CR13","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2016.02.043","volume":"164","author":"G Karsenty","year":"2016","unstructured":"Karsenty G, Olson EN. Bone and muscle endocrine functions: unexpected paradigms of inter-organ communication. Cell. 2016;164(6):1248\u201356.","journal-title":"Cell"},{"issue":"5","key":"7533_CR14","doi-asserted-by":"publisher","first-page":"758","DOI":"10.4158\/EP12141.RA","volume":"18","author":"AR Guntur","year":"2012","unstructured":"Guntur AR, Rosen CJ. Bone as an endocrine organ. Endocr Pract. 2012;18(5):758\u201362.","journal-title":"Endocr Pract"},{"issue":"5","key":"7533_CR15","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s00259-020-05071-8","volume":"48","author":"JP Pijl","year":"2021","unstructured":"Pijl JP, Kwee TC, Slart RHJA, et al. Clinical implications of increased uptake in bone marrow and spleen on FDG-PET in patients with bacteremia. Eur J Nucl Med Mol Imaging. 2021;48(5):1467\u201377.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7533_CR16","doi-asserted-by":"publisher","first-page":"16004","DOI":"10.1038\/boneres.2016.4","volume":"4","author":"ML Zoch","year":"2016","unstructured":"Zoch ML, Abou DS, Clemens TL, Thorek DL, Riddle RC. In vivo radiometric analysis of glucose uptake and distribution in mouse bone. Bone Res. 2016;4:16004.","journal-title":"Bone Res"},{"issue":"1","key":"7533_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41413-023-00268-7","volume":"11","author":"W Lu","year":"2023","unstructured":"Lu W, Duan Y, Li K, Qiu J, Cheng Z. Glucose uptake and distribution across the human skeleton using state-of-the-art total-body PET\/CT. Bone Res. 2023;11(1):36.","journal-title":"Bone Res"},{"issue":"17","key":"7533_CR18","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1016\/j.cell.2023.07.025","volume":"186","author":"SP Gadani","year":"2023","unstructured":"Gadani SP, Calabresi PA. The calvaria stands alone: unique aspects of the skull bone marrow-meninges border. Cell. 2023;186(17):3524\u20136.","journal-title":"Cell"},{"issue":"17","key":"7533_CR19","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1016\/j.cell.2023.07.009","volume":"186","author":"ZI Kolabas","year":"2023","unstructured":"Kolabas ZI, Kuemmerle LB, Perneczky R, et al. Distinct molecular profiles of skull bone marrow in health and neurological disorders. Cell. 2023;186(17):3706\u2013e372529.","journal-title":"Cell"},{"issue":"10","key":"7533_CR20","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/mds.27802","volume":"34","author":"S Heinzel","year":"2019","unstructured":"Heinzel S, Berg D, Gasser T, et al. Update of the MDS research criteria for prodromal parkinson\u2019s disease. Mov Disord. 2019;34(10):1464\u201370.","journal-title":"Mov Disord"},{"issue":"12","key":"7533_CR21","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for parkinson\u2019s disease. Mov Disord. 2015;30(12):1591\u2013601.","journal-title":"Mov Disord"},{"issue":"3","key":"7533_CR22","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00415-016-8370-2","volume":"264","author":"J Li","year":"2017","unstructured":"Li J, Jin M, Wang L, Qin B, Wang K. MDS clinical diagnostic criteria for parkinson\u2019s disease in China. J Neurol. 2017;264(3):476\u201381.","journal-title":"J Neurol"},{"issue":"8","key":"7533_CR23","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/mds.29062","volume":"37","author":"G Du","year":"2022","unstructured":"Du G, Wang E, Sica C, et al. Dynamics of nigral iron accumulation in parkinson\u2019s disease: from diagnosis to late stage. Mov Disord. 2022;37(8):1654\u201362.","journal-title":"Mov Disord"},{"issue":"4","key":"7533_CR24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1136\/jcp.19.4.389","volume":"19","author":"R Hume","year":"1966","unstructured":"Hume R. Prediction of lean body mass from height and weight. J Clin Pathol. 1966;19(4):389\u201391.","journal-title":"J Clin Pathol"},{"issue":"12","key":"7533_CR25","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.2967\/jnumed.114.143958","volume":"55","author":"S Roy","year":"2014","unstructured":"Roy S, Wang WT, Carass A, Prince JL, Butman JA, Pham DL. PET Attenuation correction using synthetic CT from ultrashort echo-time MR imaging. J Nucl Med. 2014;55(12):2071\u20137.","journal-title":"J Nucl Med"},{"key":"7533_CR26","doi-asserted-by":"publisher","first-page":"110672","DOI":"10.1016\/j.brainresbull.2023.110672","volume":"199","author":"C Dai","year":"2023","unstructured":"Dai C, Tan C, Zhao L, et al. Glucose metabolism impairment in parkinson\u2019s disease. Brain Res Bull. 2023;199:110672.","journal-title":"Brain Res Bull"},{"issue":"1","key":"7533_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40035-025-00467-8","volume":"14","author":"L Chen","year":"2025","unstructured":"Chen L, Wang C, Qin L, Zhang H. Parkinson\u2019s disease and glucose metabolism impairment. Transl Neurodegener. 2025;14(1):10.","journal-title":"Transl Neurodegener"},{"key":"7533_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.pneurobio.2016.10.001","volume":"145\u2013146","author":"D Athauda","year":"2016","unstructured":"Athauda D, Foltynie T. Insulin resistance and parkinson\u2019s disease: a new target for disease modification? Prog Neurobiol. 2016;145\u2013146:98\u2013120.","journal-title":"Prog Neurobiol"},{"issue":"6","key":"7533_CR29","doi-asserted-by":"publisher","first-page":"e13031","DOI":"10.1111\/acel.13031","volume":"18","author":"BG Trist","year":"2019","unstructured":"Trist BG, Hare DJ, Double KL. Oxidative stress in the aging substantia Nigra and the etiology of parkinson\u2019s disease. Aging Cell. 2019;18(6):e13031.","journal-title":"Aging Cell"},{"issue":"Suppl 1","key":"7533_CR30","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/jnc.13731","volume":"139","author":"A Bose","year":"2016","unstructured":"Bose A, Beal MF. Mitochondrial dysfunction in parkinson\u2019s disease. J Neurochem. 2016;139(Suppl 1):216\u201331.","journal-title":"J Neurochem"},{"issue":"7","key":"7533_CR31","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/cells12071012","volume":"12","author":"S Isik","year":"2023","unstructured":"Isik S, Yeman Kiyak B, Akbayir R, Seyhali R, Arpaci T. Microglia mediated neuroinflammation in parkinson\u2019s disease. Cells. 2023;12(7):1012.","journal-title":"Cells"},{"key":"7533_CR32","doi-asserted-by":"publisher","first-page":"104700","DOI":"10.1016\/j.nbd.2019.104700","volume":"134","author":"Z Chen","year":"2020","unstructured":"Chen Z, Li G, Liu J. Autonomic dysfunction in parkinson\u2019s disease: implications for pathophysiology, diagnosis, and treatment. Neurobiol Dis. 2020;134:104700.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"7533_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41467-019-14003-6","volume":"11","author":"MM Weivoda","year":"2020","unstructured":"Weivoda MM, Chew CK, Monroe DG, et al. Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism. Nat Commun. 2020;11(1):87.","journal-title":"Nat Commun"},{"issue":"3","key":"7533_CR34","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1210\/er.2017-00064","volume":"38","author":"WC Lee","year":"2017","unstructured":"Lee WC, Guntur AR, Long F, Rosen CJ. Energy metabolism of the osteoblast: implications for osteoporosis. Endocr Rev. 2017;38(3):255\u201366.","journal-title":"Endocr Rev"},{"issue":"4","key":"7533_CR35","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.joca.2020.02.027","volume":"28","author":"K Sun","year":"2020","unstructured":"Sun K, Luo J, Guo J, Yao X, Jing X, Guo F. The PI3K\/AKT\/mTOR signaling pathway in osteoarthritis: a narrative review. Osteoarthritis Cartilage. 2020;28(4):400\u20139.","journal-title":"Osteoarthritis Cartilage"},{"issue":"2","key":"7533_CR36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00198-022-06523-7","volume":"34","author":"F Marini","year":"2023","unstructured":"Marini F, Giusti F, Palmini G, Brandi ML. Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders. Osteoporos Int. 2023;34(2):213\u201338.","journal-title":"Osteoporos Int"},{"issue":"9","key":"7533_CR37","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1002\/oby.24068","volume":"32","author":"Z Li","year":"2024","unstructured":"Li Z, Zheng L, Wang J, et al. Dopamine in the regulation of glucose and lipid metabolism: a narrative review. Obesity. 2024;32(9):1632\u201345.","journal-title":"Obesity"},{"issue":"10","key":"7533_CR38","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1097\/MNM.0000000000000720","volume":"38","author":"I Sarikaya","year":"2017","unstructured":"Sarikaya I, Elgazzar AH, Sarikaya A, Alfeeli M. Normal bone and soft tissue distribution of fluorine-18-sodium fluoride and artifacts on 18F-NaF PET\/CT bone scan: a pictorial review. Nucl Med Commun. 2017;38(10):810\u20139.","journal-title":"Nucl Med Commun"},{"issue":"12","key":"7533_CR39","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.2967\/jnumed.110.077933","volume":"51","author":"J Czernin","year":"2010","unstructured":"Czernin J, Satyamurthy N, Schiepers C. Molecular mechanisms of bone 18F-NaF deposition. J Nucl Med. 2010;51(12):1826\u20139.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07533-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07533-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07533-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:46:43Z","timestamp":1769222803000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07533-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["7533"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07533-3","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki and was approved by Institutional Review Board of Xuanwu Hospital, Capital Medical University. All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}